16-OH-E1

Optimal result: 0.7 – 2.6 ng/mg

- Higher levels of the 16 pathway are associated with breast cancer, obesity, hypothyroidism, pesticide toxicity (organochlorines), high Omega-6 fatty acids, and inflammatory cytokines.

- 16-OH-E1 has been shown to encourage tumor development

Lowering levels of 16aOH-E1 have been achieved via indole-3-carbinol or one of its metabolites, di-indol methane (DIM). Soy and flax meal have also been shown to lower 16aOH-E1 levels.

Low 16-OH-E1 on a DUTCH Test: What Does It Mean?

What is 16-OH-E1?

16α-Hydroxyestrone (16-OH-E1) is one of the three major estrogen metabolites in the body, formed when estrone (E1) is metabolized through the 16-hydroxy pathway. This pathway leads to the production of estriol (E3), the weakest of the three primary estrogens (estradiol, estrone, and estriol).

16-OH-E1 is often considered a proliferative estrogen, meaning it has stronger estrogenic effects compared to 2-OH-E1 (which is protective and anti-proliferative) and 4-OH-E1 (which can be more reactive and potentially damaging if not properly detoxified).


What Do Low 16-OH-E1 Levels Mean?

1. Low Estrogen Metabolism via the 16-Hydroxy Pathway

Since 16-OH-E1 is a downstream estrogen metabolite, low levels may suggest reduced estrogen metabolism through this pathway. This could be due to:

  • Low overall estrogen production (look at estrone (E1) and estradiol (E2) levels for confirmation).
  • A genetic tendency toward favoring the 2-OH or 4-OH pathways instead.
  • Liver or gut issues affecting estrogen metabolism and detoxification.

2. Low Estriol (E3) Production

Since 16-OH-E1 is a precursor for estriol (E3), low levels may contribute to:

  • Reduced estriol levels, which is especially relevant for pregnancy and vaginal health.
  • Increased vulnerability to vaginal dryness, irritation, and urinary tract issues, particularly in postmenopausal women.

3. Possible Hypothyroidism or Impaired Detoxification

  • Low thyroid function (hypothyroidism) has been linked to decreased 16-OH-E1 metabolism.
  • Liver congestion, poor detoxification, or gut dysbiosis may also reduce estrogen metabolism through the 16-hydroxy pathway.

4. Reduced Estrogenic Stimulation of Tissues

Because 16-OH-E1 is more estrogenic than 2-OH-E1, lower levels may lead to:

  • Lower overall estrogenic activity in tissues such as breast, bones, and the uterus.
  • Lower bone density and weaker connective tissue integrity in some cases, particularly in postmenopausal women.

Potential Symptoms of Low 16-OH-E1

Individuals with low 16-OH-E1 levels may experience symptoms of low estrogen metabolism or reduced estrogenic effects, including:

  • Dry skin, vaginal dryness, or thinning of vaginal tissues
  • Weaker bones (osteopenia/osteoporosis risk, especially postmenopause)
  • Reduced libido and sexual dysfunction
  • Low energy, poor mood, or brain fog
  • Possible thyroid dysfunction symptoms (fatigue, hair thinning, weight gain)

Key Factors That Can Contribute to Low 16-OH-E1

1. Low Overall Estrogen Levels

  • If estrone (E1) and estradiol (E2) are low, 16-OH-E1 may also be low due to low estrogen production overall.

2. Genetic Differences in Estrogen Metabolism

  • Some individuals naturally favor the 2-hydroxy or 4-hydroxy estrogen pathways, which could result in low 16-OH-E1 levels.

3. Poor Liver Function or Detoxification

  • The liver is responsible for estrogen metabolism, and liver congestion, poor bile flow, or a high toxic burden can alter estrogen processing.
  • Glucuronidation and sulfation pathways in the liver and gut microbiome influence estrogen metabolism.

4. Gut Dysbiosis and Impaired Estrobolome Function

  • The estrobolome (the collection of gut bacteria that metabolizes estrogens) plays a role in estrogen recycling and excretion.
  • Dysbiosis, constipation, or poor gut health can alter estrogen metabolism and reduce the 16-OH pathway activity.

5. Low Thyroid Function (Hypothyroidism)

  • Thyroid hormones influence estrogen metabolism, and hypothyroidism has been linked to low 16-OH-E1 levels.
  • If you suspect thyroid issues, check TSH, free T3, and free T4.

Next Steps: How to Support Healthy 16-OH-E1 Levels

1. Assess Overall Estrogen Levels

  • Check estrone (E1) and estradiol (E2) levels to determine if low estrogen production is contributing to low 16-OH-E1.
  • Consider hormonal support strategies (if needed) under medical guidance.

2. Support Liver Detoxification

  • Eat cruciferous vegetables (broccoli, cauliflower, Brussels sprouts) to support healthy estrogen metabolism.
  • Ensure adequate intake of B vitamins (B6, B12, folate), magnesium, and glutathione precursors to aid phase I and phase II liver detoxification.
  • Reduce alcohol and processed foods that burden the liver.

3. Improve Gut Health and Estrogen Metabolism

  • Increase fiber intake (flaxseeds, vegetables, whole grains) to support healthy estrogen clearance.
  • Support a balanced microbiome with probiotics and fermented foods.
  • Address constipation, as sluggish digestion can lead to estrogen recycling and imbalanced estrogen metabolism.

4. Consider Thyroid Function

  • If symptoms of fatigue, cold intolerance, dry skin, or hair thinning are present, assess thyroid hormones (TSH, free T3, free T4, reverse T3, and thyroid antibodies).

5. Lifestyle Adjustments

  • Engage in regular physical activity, as exercise improves estrogen metabolism and hormone balance.
  • Manage chronic stress, since prolonged stress can alter HPA axis function, impacting estrogen metabolism.

Final Thoughts

Low 16-OH-E1 levels on a DUTCH test may indicate low overall estrogen metabolism, poor liver detoxification, thyroid dysfunction, or gut imbalances. Since 16-OH-E1 is a precursor to estriol (E3), lower levels may impact bone health, vaginal health, and estrogenic stimulation of tissues.

By evaluating overall estrogen levels, supporting detoxification pathways, and addressing potential thyroid or gut issues, you can optimize hormonal balance and estrogen metabolism for better health.

16α-Hydroxyestrone (16α-OH-E1), or hydroxyestrone, also known as estra-1,3,5(10)-trien-3,16α-diol-17-one, is an endogenous steroidal estrogen and a major metabolite of estrone, as well as an intermediate in the biosynthesis of estriol. It is a potent estrogen similarly to estrone, and it has been suggested that the ratio of 16α-hydroxyestrone to 2-OH-E1, the latter being much less estrogenic in comparison and even antiestrogenic in the presence of more potent estrogens like estradiol, may be involved in the pathophysiology of breast cancer. Conversely, 16α-hydroxyestrone may help to protect against osteoporosis.

Both 16a-OHE1 and 4-OHE1 have been referred to as the “bad” estrogens.

- This estrogen metabolite is a more potent estrogen than the other two (2-OH and 4-OH). If this value is elevated, we may see estrogen dominance. 

- Estrogen is also metabolized through the ’16’ pathway. We need this route however it should be used significantly less than the 2-OH pathway. Phase 1 in the 16-Hydroxyestrone pathway is also hydroxylation. Phase 2 is a reduction phase that produces Estriol which is a weak estrogen.

16α-Hydroxyestrone (16α-OH-E1), or hydroxyestrone, also known as estra-1,3,5(10)-trien-3,16α-diol-17-one, is an endogenous steroidal estrogen and a major metabolite of estrone, as well as an intermediate in the biosynthesis of estriol. It is a potent estrogen similarly to estrone, and it has been suggested that the ratio of 16α-hydroxyestrone to 2-OH-E1, the latter being much less estrogenic in comparison and even antiestrogenic in the presence of more potent estrogens like estradiol, may be involved in the pathophysiology of breast cancer. Conversely, 16α-hydroxyestrone may help to protect against osteoporosis.

Synthetic and Natural Estrogens:

Estrone (E1), estradiol (E2) and estriol (E3) are the three estrogens. Synthetic estrogen (premarin) is made up of E1 and E2 estrogen. E1 is the main estrogen that the body makes post menopausally, and most researchers believe that high E1 levels increase the risk of breast cancer. 

Estrogen Metabolism:

The metabolism of estrogen in women changes after menopause. The body metabolizes estrogen into two major pathways and one minor. The two major are 2 and 16-hydroxyeone (2-OH and 16 OH, respectively). The minor pathway is 4-hydroxyestrone (4-OH). 2-OH is the good metabolite. 2-OH does not stimulate cell growth and it blocks the action of stronger estrogens that may be carcinogenic. 

16-OH has a significantly stronger estrogenic activity, and studies show that it may increase the risk of breast cancer. 

4-OH is also not desirable as it may directly damage DNA and cause mutations, thus it is thought to promote cancer development. Premarin breaks down exclusively into 4-hydroxyestrogen.

16-OH-E1
Healthmatters dashboard showing biomarker trend graph

Every lab result you’ve ever had, charted and explained.

Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.

Start with my report →
Beyond 16-OH-E1 — 10,000+ markers explained
One 16-OH-E1 result tells you where you are. Your history tells you where you’re heading. Upload your past lab reports and see this marker — and every marker on them —every marker charted against your own lab’s ranges.
Start with this report →
Healthmatters timeline preview showing biomarker trends over time
Clinical Sources & References

All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.

Article Review Log
Written by Healthmatters Editorial Team
Healthmatters Lifetime Plan

Pay $250. Track your health forever

One payment. No renewals. Yours for life.

10,000+ biomarkers explained · trends over time

See other plans →
Secure checkout via Stripe · GDPR & HIPAA
We accept results from any lab
LabCorp Quest Diagnostics Genova Diagnostics DUTCH Test Doctor's Data Vibrant America ZRT Laboratory Cyrex Labs + any other lab

What members are saying

★★★★★ 10,000+ happy members
★★★★★

"Watching my numbers move over the years — instead of forgetting last time's results — completely changed how I manage my health."

Daniel
Member since 2022
★★★★★

"Living across several countries made keeping my lab results organized a real challenge. Healthmatters brought my results from the USA, Spain, and Germany together — 20 years of history, with long-term trends instead of scattered reports."

Ben
Member since 2021 · tracks across countries
★★★★★

"Standard lab ranges are too wide for how I practice — 'normal' isn't optimal. I set my own bands, so a client sees yellow before a marker goes officially out of range. That's the conversation I want to be having."

Dr. Alexandra
Functional medicine · 6 yrs on Pro